Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Medical Faculty Heidelberg, Heidelberg University, 69120 Heidelberg, Germany.
Nutrients. 2022 Aug 11;14(16):3282. doi: 10.3390/nu14163282.
Serum 25-hydroxyvitamin (25(OH)D) levels are inversely associated with risk of diabetes. The "free hormone hypothesis" suggests potential effects to be mainly related to concentrations of "bioavailable" and free rather than total 25(OH)D. We assessed associations of serum concentrations of vitamin D-binding protein (VDBP), as well as total "bioavailable", complementary "non-bioavailable", and free 25(OH)D, with the risk of developing diabetes among non-diabetic older adults in a large population-based cohort study in Germany.
We included 4841 non-diabetic older adults aged 50-75 years at the baseline exam from the ESTHER cohort conducted in Saarland, Germany, in 2001-2002. Concentrations of "bioavailable" and free 25(OH)D were derived from serum concentrations of VDBP, total 25(OH)D, and albumin. Incidence of diabetes was ascertained during up to 14 years of follow-up. Associations were quantified by multivariable Cox proportional hazards regression models with comprehensive confounder adjustment.
During a median follow-up of 10.6 years, 837 non-diabetic participants developed diabetes. We observed similar inverse associations with developing diabetes for VDBP (hazard ratio (HR) for lowest versus highest quintile: 1.37, 95% confidence interval (CI): 1.09, 1.72), total 25(OH)D (HR: 1.31, 95% CI: 1.03, 1.66), and "non-bioavailable" 25(OH)D (HR: 1.30, 95% CI: 1.02, 1.65). Associations were smaller and statistically insignificant for "bioavailable" and free 25(OH)D. However, associations of total "non-bioavailable", "bioavailable", and free 25(OH)D with incidence of diabetes were much stronger among, and essentially restricted to, participants with lower baseline HbA (≤6%) levels.
This large prospective cohort study of older Caucasian adults, in agreement with results from randomized trials and Mendelian randomization studies, supports a protective effect of vitamin D against development of diabetes. The "free hormone theory" may not be relevant in this context. However, our results underline the importance of adequate vitamin D status among those who have not yet shown any sign of impaired glucose tolerance.
血清 25-羟维生素(25(OH)D)水平与糖尿病风险呈负相关。“游离激素假说”表明,潜在的作用主要与“生物可利用”和游离而非总 25(OH)D 的浓度有关。我们评估了维生素 D 结合蛋白(VDBP)血清浓度,以及总“生物可利用”、补充“非生物可利用”和游离 25(OH)D 与德国一项大型基于人群的队列研究中无糖尿病的老年成年人发生糖尿病的风险之间的关联。
我们纳入了 2001-2002 年在德国萨尔州进行的 ESTHER 队列中的 4841 名基线检查时年龄在 50-75 岁之间的无糖尿病的老年成年人。“生物可利用”和游离 25(OH)D 的浓度是从 VDBP、总 25(OH)D 和白蛋白的血清浓度中推导出来的。在长达 14 年的随访期间确定了糖尿病的发病率。通过多变量 Cox 比例风险回归模型,在全面调整混杂因素后,对关联进行了量化。
在中位随访 10.6 年期间,837 名无糖尿病参与者发生了糖尿病。我们观察到与 VDBP(最低五分位数与最高五分位数的比值比(HR):1.37,95%置信区间(CI):1.09,1.72)、总 25(OH)D(HR:1.31,95%CI:1.03,1.66)和“非生物可利用”25(OH)D(HR:1.30,95%CI:1.02,1.65)的发展呈类似的负相关。对于“生物可利用”和游离 25(OH)D,关联较小且统计学上不显著。然而,总“非生物可利用”、“生物可利用”和游离 25(OH)D 与糖尿病发病率的关联在基线 HbA(≤6%)水平较低的参与者中更强,且基本上仅限于这些参与者。
这项针对老年白种成年人的大型前瞻性队列研究与随机试验和孟德尔随机化研究的结果一致,支持维生素 D 对预防糖尿病发生的保护作用。“游离激素理论”在这种情况下可能并不相关。然而,我们的结果强调了在尚未出现任何葡萄糖耐量受损迹象的人群中保持足够的维生素 D 状态的重要性。